Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients
Authors:
- L. Del MastroLML. Del Mastro
- M. VenturiniMVM. Venturini
- M. BergaglioMBM. Bergaglio
- A. SignoriniASA. Signorini
- C. BighinCBC. Bighin
- G. BertelliGBG. Bertelli
- C. SeminoCSC. Semino
- G. PietraGPG. Pietra
Open Access
- 1 April 2001
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (4) , 505-508
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Planned progressive antimicrobial therapy in neutropenic patientsBritish Journal of Haematology, 1998
- Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis.Journal of Clinical Oncology, 1998
- Anaphylaxis during autologous peripheral blood progenitor cell infusionBone Marrow Transplantation, 1997
- An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsEuropean Journal of Cancer, 1995
- Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapyCancer, 1994
- Reversible encephalopathy after cryopreserved peripheral blood stem cell infusionAmerican Journal of Hematology, 1994
- Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancerTransfusion, 1993
- Clinical toxicity of cryopreserved bone marrow graft infusionBlood, 1990
- Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancerGynecologic Oncology, 1984
- SAFETY OF DIMETHYLSULPHOXIDEThe Lancet, 1981